The trial evaluates survival outcomes for recurrent head and neck squamous cell carcinoma post-radiation therapy, comparing ...
Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.
A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...
Zacks Investment Research on MSN
Novartis' ianalumab wins breakthrough therapy tag for Sjogren's disease
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the ...
Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results